Zi-Jia Zhang1,2,3, Hong-Lei Qu4, Na Zhao3, Jing Wang3, Xiu-Yan Wang3, Rong Hai3,5, Bin Li1. 1. Department of General Surgery, Suzhou Ninth People's Hospital, Suzhou, China. 2. Inner Mongolia Medical University, Hohhot, China. 3. Inner Mongolia Autonomous Region People's Hospital, Hohhot, China. 4. Suzhou Hospital of Anhui Medical University, Anhui, China. 5. Inner Mongolia Autonomous Region Health Management Service Center, Hohhot, China.
Abstract
BACKGROUND: Recent studies have shown that the gut microbiota is closely related to the pathogenesis of Inflammatory Bowel Disease (IBD), but the causal nature is largely unknown. The purpose of this study was to assess the causal relationship between intestinal bacteria and IBD and to identify specific pathogenic bacterial taxa via the Mendelian randomization (MR) analysis. MATERIALS AND METHODS: MR analysis was performed on genome-wide association study (GWAS) summary statistics of gut microbiota and IBD. Specifically, the TwinsUK microbiota GWAS (N = 1,126 twin pairs) was used as exposure. The UK inflammatory bowel disease (UKIBD) and the Understanding Social Program (USP) study GWAS (N = 48,328) was used as discovery outcome, and the British IBD study (N = 35,289) was used as replication outcome. SNPs associated with bacteria abundance at the suggestive significance level (α = 1.0 × 10-5) were used as instrumental variables. Bacteria were grouped into families and genera. RESULTS: In the discovery sample, a total of 30 features were available for analysis, including 15 families and 15 genera. Three features were nominally significant, including one family (Verrucomicrobiaceae, 2 IVs, beta = -0.04, p = 0.05) and two genera (Akkermansia, 2 IVs, beta = 0.04, p = 0.05; Dorea, 2 IVs, beta = -0.07, p = 0.04). All of them were successfully replicated in the replication sample (Verrucomicrobiaceae and Akkermansia P replication = 0.02, Dorea P replication = 0.01) with consistent effect direction. CONCLUSION: We identified specific pathogenic bacteria features that were causally associated with the risk of IBD, thus offering new insights into the prevention and diagnosis of IBD.
BACKGROUND: Recent studies have shown that the gut microbiota is closely related to the pathogenesis of Inflammatory Bowel Disease (IBD), but the causal nature is largely unknown. The purpose of this study was to assess the causal relationship between intestinal bacteria and IBD and to identify specific pathogenic bacterial taxa via the Mendelian randomization (MR) analysis. MATERIALS AND METHODS: MR analysis was performed on genome-wide association study (GWAS) summary statistics of gut microbiota and IBD. Specifically, the TwinsUK microbiota GWAS (N = 1,126 twin pairs) was used as exposure. The UK inflammatory bowel disease (UKIBD) and the Understanding Social Program (USP) study GWAS (N = 48,328) was used as discovery outcome, and the British IBD study (N = 35,289) was used as replication outcome. SNPs associated with bacteria abundance at the suggestive significance level (α = 1.0 × 10-5) were used as instrumental variables. Bacteria were grouped into families and genera. RESULTS: In the discovery sample, a total of 30 features were available for analysis, including 15 families and 15 genera. Three features were nominally significant, including one family (Verrucomicrobiaceae, 2 IVs, beta = -0.04, p = 0.05) and two genera (Akkermansia, 2 IVs, beta = 0.04, p = 0.05; Dorea, 2 IVs, beta = -0.07, p = 0.04). All of them were successfully replicated in the replication sample (Verrucomicrobiaceae and Akkermansia P replication = 0.02, Dorea P replication = 0.01) with consistent effect direction. CONCLUSION: We identified specific pathogenic bacteria features that were causally associated with the risk of IBD, thus offering new insights into the prevention and diagnosis of IBD.
Authors: Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard Journal: Am J Gastroenterol Date: 2006-07 Impact factor: 10.864
Authors: Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn Journal: Inflamm Bowel Dis Date: 2007-03 Impact factor: 5.325
Authors: David Kevans; Mark S Silverberg; Krzysztof Borowski; Anne Griffiths; Wei Xu; Venus Onay; Andrew D Paterson; Jo Knight; Ken Croitoru Journal: J Crohns Colitis Date: 2015-10-28 Impact factor: 9.071
Authors: Gibran Hemani; Jie Zheng; Benjamin Elsworth; Tom R Gaunt; Philip C Haycock; Kaitlin H Wade; Valeriia Haberland; Denis Baird; Charles Laurin; Stephen Burgess; Jack Bowden; Ryan Langdon; Vanessa Y Tan; James Yarmolinsky; Hashem A Shihab; Nicholas J Timpson; David M Evans; Caroline Relton; Richard M Martin; George Davey Smith Journal: Elife Date: 2018-05-30 Impact factor: 8.140
Authors: Carlos G Gonzalez; Robert H Mills; Melissa C Kordahi; Marvic Carrillo-Terrazas; Henry Secaira-Morocho; Christella E Widjaja; Matthew S Tsai; Yash Mittal; Brian A Yee; Fernando Vargas; Kelly Weldon; Julia M Gauglitz; Clara Delaroque; Consuelo Sauceda; Leigh-Ana Rossitto; Gail Ackermann; Gregory Humphrey; Austin D Swafford; Corey A Siegel; Jay C Buckey; Laura E Raffals; Charlotte Sadler; Peter Lindholm; Kathleen M Fisch; Mark Valaseck; Arief Suriawinata; Gene W Yeo; Pradipta Ghosh; John T Chang; Hiutung Chu; Pieter Dorrestein; Qiyun Zhu; Benoit Chassaing; Rob Knight; David J Gonzalez; Parambir S Dulai Journal: Cell Mol Gastroenterol Hepatol Date: 2022-04-01